We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Co-founders TommyD and Paul Pullinger have created a signature whisky blend to define the music loving generation of today. 8O8 has all the heritage, depth and soul of a classic scotch, but has been shaped for the 21st century. It has been blended to be enjoyed on its own, but is also versatile to be mixed into a cocktail. 
days to go: Expired investment: £954,496
Kiddyum have won multiple awards for their nutritious and delicious frozen meals for young children. They are currently stocked in over 320 sainsbury's nationwide and on Ocado.com. All ready meals are made from natural ingredients with no added sugar, preservatives, GM ingredients or artificial colours or flavours.
days to go: Expired investment: £61,310
Run An Empire is a mobile app that is encouraging people to get outside and start jogging/ running more often using gamification. The idea behind the app is that users run around a particular area and then that area is claimed as their 'territory' until another user jogs that area and then claims it. 
days to go: Expired investment: £60,370
We created FlyFit with the aim to change the way people travel. Air travel can be stressful, lonely, and unhealthy. On top of this, with average layovers of 2+ hours, flight delays, and hours waiting in security, there is too much unproductive time in airports with limited healthy options to choose from.
days to go: Expired investment: £500,060
Equal Health's (EH) mission is to create a healthy organic food brand that makes a difference to the environment and its customers' health. The company wants to become the go-to brand for healthy organic meals. EH uses seasonal organic ingredients which are ethically sourced, cooked and packed in its kitchen by its expert team of chefs. It received its organic status through the UK's leading certification body, The Soil Association. It aims to launch a new range of healthy organic frozen meals. EH will use the investment to focus on digital marketing, increase its kitchen facilities, and invest in New Product Development (NPD).

Pitch Rated

43%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £226,598
L'orchidee is a boutique patisserie concept that specialises in macaroons and cakes for all occasions. L'orchidee currently have 3 stores with their most successful store recently opening in Canary Wharf. 
days to go: Expired investment: £33,480
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph